1. Home
  2. DCTH vs AGL Comparison

DCTH vs AGL Comparison

Compare DCTH & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • AGL
  • Stock Information
  • Founded
  • DCTH 1988
  • AGL 2016
  • Country
  • DCTH United States
  • AGL United States
  • Employees
  • DCTH N/A
  • AGL N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • AGL Managed Health Care
  • Sector
  • DCTH Health Care
  • AGL Health Care
  • Exchange
  • DCTH Nasdaq
  • AGL Nasdaq
  • Market Cap
  • DCTH 388.3M
  • AGL 443.4M
  • IPO Year
  • DCTH N/A
  • AGL 2021
  • Fundamental
  • Price
  • DCTH $11.10
  • AGL $1.08
  • Analyst Decision
  • DCTH Strong Buy
  • AGL Hold
  • Analyst Count
  • DCTH 4
  • AGL 20
  • Target Price
  • DCTH $24.50
  • AGL $2.75
  • AVG Volume (30 Days)
  • DCTH 681.8K
  • AGL 6.4M
  • Earning Date
  • DCTH 11-07-2025
  • AGL 11-04-2025
  • Dividend Yield
  • DCTH N/A
  • AGL N/A
  • EPS Growth
  • DCTH N/A
  • AGL N/A
  • EPS
  • DCTH 0.06
  • AGL N/A
  • Revenue
  • DCTH $70,240,000.00
  • AGL $5,901,182,000.00
  • Revenue This Year
  • DCTH $159.22
  • AGL N/A
  • Revenue Next Year
  • DCTH $42.78
  • AGL $6.21
  • P/E Ratio
  • DCTH $197.68
  • AGL N/A
  • Revenue Growth
  • DCTH 491.35
  • AGL 11.76
  • 52 Week Low
  • DCTH $8.08
  • AGL $0.71
  • 52 Week High
  • DCTH $18.23
  • AGL $6.08
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 45.00
  • AGL 41.92
  • Support Level
  • DCTH $10.43
  • AGL $1.05
  • Resistance Level
  • DCTH $11.28
  • AGL $1.18
  • Average True Range (ATR)
  • DCTH 0.41
  • AGL 0.07
  • MACD
  • DCTH -0.02
  • AGL 0.01
  • Stochastic Oscillator
  • DCTH 23.22
  • AGL 38.46

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About AGL agilon health inc.

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

Share on Social Networks: